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Introduction
Toluene (Tol) is undoubtedly one of the most widely used organic solvents in industry.
It is a major component of adhesives, paints, varnishes, printing inks, degreasers, fuel additives, glues, thinners and plastics (Meek and Chan, 1994;  http://www.scorecard.org/chemical-profiles). In industry, the permissible upper exposure limit value of Tol exposure is 20 ppm in the USA (www.acgih.org/TLV2008list.com), but it is still 50 ppm in France (Decree n°2007-1539 , Official Journal 28/10/2007 . In addition to these industrial uses, volatile solvents, included Tol and related compounds, represent one of the largest classes of abused inhalants.
Chronic exposure to Tol, particularly in circumstances of abuse (Marjot and McLeod, 1989) can impair the central nervous system (Lazar et al., 1983; Yamanouchi et al., 1995; Greenberg, 1997) . Tol shares many effects with nervous system depressant compounds such as ethanol, barbiturates and anesthetics. For instance, it can cause prenarcotic syndrome in animals and humans (Evans and Balster, 1991) . In the past, the neuroactivity of anesthetics and related compounds was thought to be attributed to their ability to perturb the fluidity of the plasma membrane (Engelke et al., 1992) . Today, clear evidence is emerging from the literature regarding common actions of solvents and other depressant compounds on several kinds of ion channels expressed in neurons. For instance, N-methyl-D-aspartatic acid (Cruz et al., 1998) , gamma-aminobutyric acid (Krasowski and Harrison, 2000) , glycine (Beackstead et al., 2000) , adenosyl triphosphate (Woodward et al., 2004) , serotonin (Lopreato et al., 2003) and nicotinic acetylcholine (Ach) (Bale et al., 2002 (Bale et al., , 2005 receptors are all involved in the nervous system function and sensitive to Tol. In addition, Tol alters the function of different voltage-dependent ion channels (Cruz et al., 2003; Del Re et al., 2006) included voltagedependent Ca 2+ channels (VDCCs). Indeed, Tillar et al. (2002) and Shafer et al. (2005) have shown that Tol can inhibit VDCCs in in vitro conditions.
Chronic exposure to Tol can impair the inner ear as well (Johnson and Canlon, 1995; Campo et al., 1997) . The notion of ototoxicity stemming from volatile organic compounds is important, especially when people are concerned about potential workplace exposures (Morata and Campo, 2001) . Certain aromatic solvents are ototoxic by themselves and can even worsen the effects of noise in animal experiments Campo, 1997, 2000; Brandt-Lassen et al., 2000; Morioka et al., 2000; Cappaert et al., 2001; Mäkitie et al., 2003) and in industrial environments (Sliwinska-Kowalska et al., 2003; Chang et al., 2006) . On the whole, the studies carried out in the rat have shown that a co-exposure to noise and aromatic solvent can provoke a hearing loss that exceeds the summated losses caused by the noise and the solvent alone. In other words, a co-exposure to noise and solvent can have synergistic adverse effects on hearing. The fair assumption proposed to explain the synergic effects on hearing was that the aromatic solvents could weaken the outer hair cell membranes and thereby increase their vulnerability to noise. Epidemiological findings also suggest that workers exposed to noise and solvents can suffer from central alterations of the auditory pathways, and more accurately of the auditory circuits involved in the middle-ear reflex arc (Prasher et al., 2005) . Recently, Campo et al. (2007) demonstrated in vivo with rats that Tol injected via the intra-carotidal pathway can inhibit the protective effect of the middle-ear reflex in the rat. Besides, Lataye et al. (2007) demonstrated that Tol-induced middle-ear reflex inhibition occurs through Tol anticholinergic-like effects, thereby confirming the results of Bale et al. (2002 Bale et al. ( , 2005 obtained with in vitro preparations. Unfortunately, the authors did not go further in their investigations and did not test other potential molecular targets of Tol.
The motoneurons involved in the middle-ear reflex arc are mediated by acetylcholine (Ach) [Wamsley et al., 1981; Liu et al., 1998; Zaninetti et al., 1999; Keiger and Walker, 2000] . Ach is also the major neurotransmitter involved in the synaptic network within the integrator centers that are the facial and trigeminal nuclei in the rat (Lee et al., 2006) and in the neuromuscular junctions connected to effectors that are the tensor tympani and stapedial muscles. In the nervous system, Ach release is activated by VDCCs. Neuronal exocytosis is mainly activated by P/Q-type Ca 2+ channels (Wright and Angus, 1996; Day et al., 1997) and to a lesser extent by N-type Ca 2+ channels (Hamilton and Smith, 1992; Rossoni et al., 1994) .
In contrast, the L-type (dihydropyridine sensitive) Ca 2+ channels are mainly dedicated to muscular contraction (Catterall et al., 1988; Patterson et al., 1995) and consequently not present in high density in nerves. Indeed, only a small percentage of L-type Ca 2+ channels are expressed in the facial (Plant et al., 1998) and trigeminal (Oh et al., 2003; Hsiao et al., 2005) motoneurons constituting the efferent pathway of the middle-ear reflex in the rat (Fig. 1 ).
Insert figure 1 about here
There is therefore a dominating role of P/Q-and N-type Ca 2+ channels at motoneuron level and a dominating role of L-type Ca 2+ channels in the muscles.
Although the inhibiting action of Tol on the middle-ear reflex has previously been demonstrated with in vivo rats , the cellular and molecular sites of its action have still not been completely elucidated. In the present study, the sensitivity of two specific VDCC blockers, ω-conotoxin MVIIC (ω-Ctx) and verapamil, was investigated and compared to that of Tol in order to (1) test the VDCCs as potential molecular targets, (2) localize the cellular sites perturbed by the solvent in the middle-ear reflex arc. The two specific VDCCs blockers used in the present in vivo study were:
-ω-Ctx, which is the only pharmacological tool inhibiting both P/Q-and N-type Ca 2+ channels (Hillyard et al., 1992; Olivera et al., 1994 , McDonough et al., 1996 expressed in neurons,
-verapamil, which inhibits the L-type Ca 2+ channels, these being expressed mainly in muscular fibers (Almers et al., 1985) .
Like Tol, these blockers have been administered in the rat by intra-carotidal injections to study their effects on the cochlear microphonic potential (CMP), which is a good electrophysiological tool to record (1) the electro-activity of the outer hair cells (Withnell, 2001) and (2) the triggering of the middle-ear reflex (Dancer and Franke, 1980; Lataye et al., 2007; Campo et al., 2007) . On the other hand, some lines of evidence suggested that acute exposures to Tol could lead to neuron apoptosis (Lin et al., 2002; Yan et al., 2004) . Due to the administration pathway of Tol in the present study (Kastin et al., 1976) , it was therefore reasonable to check the rate of neuronal apoptosis in the trigeminal and facial nuclei located in the brainstem of the experimented rats. For this reason, in addition to the use of VDCC blockers to pinpoint the adverse effects of Tol, TUNEL staining was performed on brainstem slides to test a possible neurotoxic effect of Tol in the central nervous system.
The aim of this investigation was to study the prevailing action of Tol on the different elements of the middle-ear reflex arc. To this end, two types of VDCC antagonists, a neuronal and a muscular blocker, were injected into the carotid artery to compare their effects with those of Tol administered in the same experimental conditions. The inhibition of the middleear reflex arc by these blockers was measured with a setup recently developed for monitoring the CMP during a controlled injection of solvent into the carotid artery in anesthetized rats . The electrophysiological study was completed by a histological analysis to detect any possible apoptotic effects due to Tol-neurotoxic effects in the brainstem.
Material and methods

Animals
A total of 30 Sprague Dawley rats obtained from Charles River Laboratories in France was used throughout this investigation. The weight of the animals was always over 350 g in this series of experiments. The subjects were housed in individual cages (350 x 180 x 184 mm) with irradiated pinewood bedding (supplier: Special Diets Services, France, ref.
Gold cob 891180) two weeks before the start of the experiments. Food and tap water were available ad libitum. The animals were on a normal day/night cycle: lighting was on 12 hours per day. The room temperature in the animal quarters was controlled at 22 ± 2 °C and the relative humidity at 55 ± 10 %.
While conducting the research described in this article, the investigators adhered to the 
Anesthesia
Half an hour prior to the surgical anesthesia, levomepromazine (12.5 mg/kg) was given to animals by i.p. injection. This premedication was done to minimize stress. Deep anesthesia was induced by i.p. injection of ketamine (50 mg/kg). During the anesthesia, the core temperature of the animals was maintained at 38 °C using a heating pad control system.
Otoscopic examination was carried out to verify that the tympanic membranes were free from obstruction, infection or other abnormalities.
Experimental protocol
Each anesthetized animal was equipped with two electrodes: one reference electrode (copper screw) and one recording electrode placed on the skull and on the edge of the round window respectively. A circular custom-made catheter was implanted into the common carotid trunk.
At the end of the surgery, the rat was placed in the audiometric cabin for ten minutes before starting the CMP measurements. The baseline recording CMP was carried out every twelve seconds for 5 minutes before starting the injections. Each rat was given a first injection of vehicle followed by a second injection of a single dose of the test compound. Each rat was tested only once with one single concentration of the tested compound. Fifteen rats were tested with three different concentrations of toluene (n=5 at 58.4, 116.2 and 229.5 mM). Six rats were tested with three concentrations of ω-Ctx (n=2 at 83.5, 145.2 and 211.4 µM) and nine rats were tested with three concentrations of verapamil (n=3 at 312.5, 625 and 1250 µM).
Surgical procedures: electrodes and catheter implantations
Electrode implantation has been detailed in a previous report .
Briefly, a platinum ball electrode was inserted through a small hole made in the bulla and placed at the rim of the round window niche, whereas the ground electrode was placed over the olfactory bulb. This acute technique allows auditory-evoked potentials to be recorded from the cochlea with the tympanic bulla closed. A circular custom-made catheter filled with a solution of 0.9% NaCl and heparin (50 UI/ml) was fitted into the common carotid trunk connected to the operated ear. This catheter allowed both a normal blood flow and injection of the substances tested (see Lataye et al., 2007) .
Electrophysiological measure
The cochlear microphonic potential (CMP) was measured inside a sound-attenuated chamber (Elstar, model MR http://www.elstarprevention.com). In this chamber, the animals were placed in a custom head holder, which ensured a constant distance (15 cm) and orientation from the ipsilateral pinna to the speaker (JBL, 2405).
Acoustic stimulation
The acoustic stimulus was generated and shaped with a Tucker-Davis technologies apparatus equipped with Biosig software. The acoustic stimulus was a 2.6-s burst emitted every 12 s; its spectrum was a narrow-band noise centered at 4 kHz (4 kHz-BN) and emitted at 85 dB SPL.
Bioelectrical activity recording
The CMP was amplified 5000X and filtered from 2 to 8 kHz. The root mean square (RMS) value of the CMP amplitude was measured with a measuring amplifier Bruel and Kjaer (BK) 2636. This apparatus has an integrated filter and the particularity to read RMS values (0.01µv sensitivity). The CMP values were expressed in dB ref. 1V (dBV) .
Calibration
Acoustic calibration was carried out by measuring the sound pressure level emitted by the speaker (JBL 2405), when it was driven by a continuous noise (4 kHz-BN). The sound field was calibrated by positioning a ½ inch BK Type 4133 microphone at a point normally occupied by the center of the animal's head. The targeted intensity was obtained by adjusting the level of the continuous noise.
Chemical injection
The injections were all performed at room temperature with a driven syringe pump calibrated to deliver a 100-µL bolus of vehicle containing the substance tested for 30 s. Each animal received two injections: one bolus of vehicle alone and another bolus with freshlyprepared solution containing the chemical.
Toluene
Toluene ( 
VDCCs blockers
As in the case with Tol, a bolus of freshly-prepared vehicle containing the blocker were injected. As Tebbutt et al. (2006) demonstrated that intralipid diminishes the efficacy of verapamil, the vehicle used to inject both blockers was a 0.9 % NaCl solution.
A dose-response study was carried out to determine the concentration of Ca 2+ channel blocker capable of inducing a ~4-dB increase in the CMP similar to that obtained with 116.2 mM of Tol, our reference concentration .
• ω-Conotoxin MVIIC ω-Ctx was purchased from Sigma (CAS 147794238). This synthetic neurotoxin was
identified from the cDNA library made from the venom of the marine snail Conus magus (Hillyard et al., 1992) . This toxin blocks both P/Q-and N-type VDCCs. Three concentrations of ω-Ctx: 83.5, 145.2 and 211.4 µM, were tested with three different groups of rats (n = 2) to assess the effects of this blocker and to compare them with that previously obtained with 116.2-mM Tol.
• 
Statistical analysis
The Statgraphics centurion software (version XV) was used to run all the statistical analyses. Due to the size of the samples, tests of normality were not appropriate. Thus, a nonparametric test, Kruskal-Wallis (K), was used to determine the statistical significance of the results. Alpha levels of 0.05 (significant at 95 %) were used for the significance of the tests.
Results
In figures 3, 4, 5 and 7, each curve represents the data obtained with one of the tested animals, which was representative of the group. All the injections started at time 0 and lasted 30 s. 
Toluene effects on CMP
In the same way, there are also large differences in the area under the curve (AUC) between the variation in CMP amplitude obtained with Tol and the blockers (Fig. 3-5 ). These differences between AUC are illustrated in figure 7. This figure displays the variations in CMP amplitude obtained before, during and after a 100-µL injection of 145.2-µM ω-Ctx, 1250-µM verapamil and 116.2-mM Tol.
From a statistical point of view, while no significant difference appears between Tol and ω-Ctx (K = 3.43; p = 0.064), a significant difference (K = 4.5; p = 0.034) exists between the AUC of Tol and verapamil. For instance, the AUC ratios are
As a result, verapamil has a long-lasting effect compared to that measured with a Tol and a ω-Ctx injection. Indeed, the mean duration (duration between the injection onset and the return to baseline CMP line after injection) measured after a 116.2-mM Tol, 145.2-µM ω-Ctx and 1250-µM verapamil injection was 86.0 ± 21.9 s, 85.0 ± 9.9 s and 359.0 ± 147.0 s respectively. If the difference of duration between Tol and verapamil was significant (K = 4.5; p = 0.034), it was not significant (K = 0.0; p = 1.00) between Tol and ω-Ctx.
Insert figures 6, 7 about here
Histology
Figure 8 depicts TUNEL staining of brainstem sections 8 h after injection of 116.2-mM Tol. The positive control sections (Fig. 8 C) showed apoptotic TUNEL-labeled neuron cell nuclei. These apoptotic nuclei appeared in yellow circled with green, which is a typical pattern of apoptotic degeneration. On the contrary, the negative control sections (Fig. 8 A) showed non-specific TUNEL staining characterized by formless yellow stains. The staining of the brainstem sections obtained from Tol-exposed rats (Fig. 8 B) was comparable to that obtained with the negative control sections. As a result, Tol did not induce apoptotic neuronal degeneration within the integrator centers of the middle ear reflex.
Insert figure 8 about here
Discussion
These experiments showed that a modulation of the middle-ear reflex (MER) can modulate the CMP amplitude obtained with a noise and that several substances injected into the carotid artery can modulate the MER strength triggered by the same noise. For instances, several aromatic solvents may mimic the effects of cholinergic receptor antagonists (Bales et al., 2002 and Campo et al., 2007) . If Ach release is activated by P/Q-N-type Ca 2+ channels in the nervous system, (Wright and Angus, 1996; Day et al., 1997) , the L-type (dihydropyridine sensitive) Ca 2+ channels are mainly dedicated to muscular contraction (Catterall et al., 1988; Patterson et al., 1995) . In order to test VDCCs as potential molecular targets and localize the cellular sites perturbed by Tol at the level of the middle-ear reflex arc, the sensitivity of two specific VDCCs blockers, ω-Ctx and verapamil, was investigated and compared to that of Tol with an in vivo study.
As expected, the Tol dose-response study (Fig. 3) showed a clear middle-ear reflex inhibition, and the maximum of this inhibition (~4 dB) was obtained with 116.2-mM Tol.
Figures 4 and 5 show the reversible inhibition of the middle-ear reflex by the neuronal and muscular VDCC blockers. Moreover, figure 6 shows that the VDCC blocker-induced inhibition is concentration-dependent. The reversibility and the concentration-dependent responses are comparable with those previously obtained with cholinergic receptor
antagonists . If the 4-dB amplitude curves are compared, it can be noted that the ω-Ctx sensitivity is nine-fold higher than that of verapamil (145.2 vs. 1250 µM). This difference in sensitivity might be due to the blocker affinity for its binding-site on the ion channel and to the number of blocked ion channels required to observe the effect (Bale et al., 2005) .
Similarly to Tol, the two VDCC blockers are able to induce a reversible inhibition of the middle-ear reflex. But that does not mean that Tol can mimic the effects of both neuronal and muscular VDCC blockers. Indeed, several clear differences can be noticed between the responses induced by the two blockers with respect to that obtained with Tol. Figure 6 highlights the difference in concentration needed for the solvent (116.2 mM) and the VDCC blockers (145.2-µM ω-Ctx; 1250-µm verapamil) to induce a response with the same amplitude. In our opinion, the concentration can hardly be considered as a pertinent parameter because of the experimental conditions. Indeed, it was impossible to run the experiments with the same vehicle. Tol needed a lipophilic vehicle to be well dissolved, whereas the efficiency of verapamil was deeply depressed by intralipid (Tebbutt et al., 2006) . Since it was fundamental to keep the same experimental conditions for both blockers, we chose a saline solution as the common vehicle for the blockers. Because of this experimental bias, it seems unrealistic to compare the concentration inside the syringe for evaluating the relative affinity of Tol and that of blockers. Indeed, the most striking drawback of intralipid is that it can confine a part of the solvent, keeping the free-available part of the solvent low. Consequently, the Tol dose at the target structure is likely overestimated with respect to that inside the syringe. To measure the exact Tol concentration at the target structure, it would have been necessary to monitor its concentration in the brainstem, but that was impossible in an in vivo experiment. Thus, the most reliable approach in the present investigation was to compare the AUCs and the durations of the responses having the same amplitude regardless of the difference in concentration between solvent and blockers.
By comparing these two particular parameters (Fig. 7) , it appeared that the effects of 1250-µM verapamil (Fig. 5 ) lasted longer than those provoked by Tol (Fig. 3 ) and ω-Ctx (Fig.   4 ). This difference in duration might also be explained by the nature (muscular vs. neuronal) of the targets inhibited by the VDCC blockers. Since verapamil mainly inhibits the muscular L-type VDCCs, it is likely that the duration required for reestablishing a normal muscular contraction (cancellation of the CMP rise, Fig. 5 ) might be longer than that required for restoring a normal nervous conduction. Indeed, in case of a neuronal inhibition (ω-Ctx, Fig.   4 ), the stapedial and tensor tympani muscles were forced into a resting state yet remained functional. Nervous control of the muscular effectors was temporarily interrupted, but the middle-ear muscles retained the ability to contract. In the case of the verapamil injection (Fig.   5 ), the L-type VDCCs were inhibited in the muscular T-tubules (deep invaginations) of the plasma membrane. Now, T-tubules are the major sites for the coupling of excitation/contraction, which is the process whereby the spreading depolarization is converted into force production by muscle fibers. The L-type VDCCs are activated in response to neuronal stimulation. Activation of L-type channels causes a mechanical interaction between them and Ca
2+
-release channels located on the adjacent sarcoplasmic reticulum membrane.
This mechanical interaction between these two channels is critical to proper skeletal muscle contraction (Tanabe et al., 1988; Nakai et al., 1998; Endo, 2006) . Due to this signalization cascade required to trigger a muscular contraction, the entire process probably lasts longer than the simple reestablishment of nervous conduction.
Whatever the reasons of the relative duration of the inhibition induced by the two blockers, figure 7 shows that the AUC and the duration of Tol-induced inhibition was close to that induced by ω-Ctx. Therefore, Tol acts rather like a neuronal VDCC blocker as already suggested by Tillar et al. (2002) and Shafer et al. (2005) with in vitro experiments.
These in vivo findings confirm the in vitro data and prove for the first time that neuronal VDCC represent a potential sensitive target for Tol. In addition, since N-, P/Q-type channels constitute the major component of the Ca 2+ channels expressed in the neuronal compartment of the middle-ear reflex arc (Plant et al., 1998; Hsio et al., 2005) , it therefore seems reasonable to state that Tol can block the reflex by inhibiting the neuronal VDCCs at the level of its motoneurons and integrator centers.
Besides, several lines of evidence showed that Tol can produce cellular toxicity in the central nervous system (Lazar et al., 1983; Yamanouchi et al., 1995; Greenberg, 1997) .
Recently, Lin et al. (2002) and Yan et al. (2004) even demonstrated that Tol could induce apoptosis events in cultured rat brainstem neurons. Therefore, it was reasonable to check the Tol-induced apoptotic events at the level of the integrator centers of the middle-ear reflex.
TUNEL staining was used to assess neuronal apoptotic degeneration. This technique allowed DNA breaks to be revealed in apoptotic cells. Although DNA fragmentation starts approximately 6 hours and continues up to 48 h after the beginning of programmed cell death (Namura et al., 1998; Lin et al., 2002) , figure 8 does not show a typical pattern of apoptotic degeneration in the brain tissues removed 8 hours post-Tol injection. Thus, it seems that Tol may have only a pharmacological action on the Ach receptors and on the VDCCs of the integrator centers involved in the middle-ear reflex arc.
In summary, the present study extends the understanding of Tol effects on the middleear acoustic reflex by characterizing its possible interaction with the neuronal VDCCs. Since
Tol has similar effects to those induced by neuronal Ca 2+ channel blockers, these findings further establish (1) neuronal Ca 2+ channels as potential molecular targets and (2) motoneurons and integrator centers of the middle-ear reflex arc as potential cellular targets of Tol. Inhibition of the transmitter receptors and associated Ca 2+ channels may constitute the central mechanism responsible for the synergistic adverse effects on hearing of a co-exposure to noise and Tol: a higher acoustic energy penetrating into the cochlea could make the noise exposure more damaging. 
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